These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7868497)

  • 21. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS
    J Clin Oncol; 1998 Mar; 16(3):1235. PubMed ID: 9508214
    [No Abstract]   [Full Text] [Related]  

  • 22. [Limphomatous meningitis as recurrence site in Hodgkin's disease].
    Greco M; Valsecchi M; Niccodemi C; Presas J; Corrado C; Winkel M
    Medicina (B Aires); 2006; 66(4):332-4. PubMed ID: 16977969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
    Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resolution of paraneoplastic bile duct paucity following successful treatment of Hodgkin's disease.
    Crosbie OM; Crown JP; Nolan NP; Murray R; Hegarty JE
    Hepatology; 1997 Jul; 26(1):5-8. PubMed ID: 9214445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The German cooperative therapy studies. An approach to minimize treatment modalities and invasive staging procedures.
    Schellong GM
    Cancer Treat Res; 1989; 41():277-89. PubMed ID: 2577082
    [No Abstract]   [Full Text] [Related]  

  • 26. Thrombocytopenic purpura as first manifestation of an inapparent Hodgkin's disease.
    Pedro-Botet J; Estruch R; Montserrat E; Urbano-Márquez A; Rozman C
    Scand J Haematol; 1986 Apr; 36(4):408-10. PubMed ID: 3754977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of risk-adapted programs of treatment of Hodgkin's disease in children and adolescents].
    Kuleva SA
    Vopr Onkol; 2008; 54(6):768-70. PubMed ID: 19241857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Will it be another 20 years before Hodgkin lymphoma patients benefit from BEACOPP therapy?
    Diehl V; Engert A
    Nat Clin Pract Oncol; 2006 May; 3(5):227. PubMed ID: 16682982
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
    Hagemeister FB; Purugganan R; Fuller L; McLaughlin P; Swan F; Romaguera J; Rodriguez M; Cabanillas F
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):36-43. PubMed ID: 8073308
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of lomustine, teniposide, procarbazine and prednisone (LTPP) in the treatment of terminal-state Hodgkin's disease].
    Robak T; Krykowski E; Olszańska-Skorek T; Urbańska-Ryś H; Dmochowska M; Chojnowski K
    Pol Tyg Lek; 1986 Feb; 41(7):199-202. PubMed ID: 3714560
    [No Abstract]   [Full Text] [Related]  

  • 32. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
    Engert A; Schiller P; Josting A; Herrmann R; Koch P; Sieber M; Boissevain F; De Wit M; Mezger J; Duhmke E; Willich N; Muller RP; Schmidt BF; Renner H; Muller-Hermelink HK; Pfistner B; Wolf J; Hasenclever D; Loffler M; Diehl V;
    J Clin Oncol; 2003 Oct; 21(19):3601-8. PubMed ID: 12913100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glomerulonephritis preceding late relapse of Hodgkin's disease.
    Lynn WA; Marcus RE
    Postgrad Med J; 1988 May; 64(751):395-7. PubMed ID: 3200784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lipoid nephrosis in a child with advanced Hodgkin's lymphoma].
    Gordillo Paniagua G; Velázquez Jones L; Scovino Gudiño R; Arroyo Sierra J; Silva Sosa M; Mota Hernández F
    Bol Med Hosp Infant Mex; 1977; 34(4):815-21. PubMed ID: 911442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
    Hudson MM; Krasin M; Link MP; Donaldson SS; Billups C; Merchant TE; Kun L; Billet AL; Kaste S; Tarbell NJ; Howard S; Friedmann AM; Hurwitz CA; Young JA; Marcus KC; Rai S; Cowan T; Weinstein HJ
    J Clin Oncol; 2004 Nov; 22(22):4541-50. PubMed ID: 15542805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study.
    Engert A; Bredenfeld H; Döhner H; Ho AD; Schmitz N; Berger D; Bacon P; Skacel T; Easton V; Diehl V
    Haematologica; 2006 Apr; 91(4):546-9. PubMed ID: 16585019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hodgkin's disease, splenectomy and secondary leukemia.
    Centurioni R; Brianzoni F; Leoni P; Danieli G
    Haematologica; 1993; 78(4):258-9. PubMed ID: 8294062
    [No Abstract]   [Full Text] [Related]  

  • 38. Occurrence of multiple myeloma 13 years after Hodgkin's disease: chance or consequence?
    Strobel ES; Bauchmüller K; Schmitt-Gräff A; Engelhardt M
    Ann Hematol; 2005 Nov; 84(12):830-2. PubMed ID: 16132908
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treating Hodgkin's disease: for whom the more means better?].
    Illés A
    Magy Onkol; 2004; 48(2):157-61. PubMed ID: 15351812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nephrotic syndrome leading to the diagnosis of classical Hodgkin's lymphoma in a 13-year-old girl.
    Escobar H; Yoshimi A; Hoffmann R; van Buiren M; Wild D; Folkens JU; Pohl M; Kontny U
    Klin Padiatr; 2012 Apr; 224(3):191-2. PubMed ID: 22513794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.